<ѻýҕl>Little Benefit With Adjuvant Therapy for High-Risk Endometrial Cancerѻýҕl> Chemo prevented relapse but did not improve survival, no benefit from radiotherapy Mar 23, 2021
<ѻýҕl>Androgen Receptor Inhibitor Active in Endometrial Cancerѻýҕl> SGO: Apatinib for platinum-resistant ovarian cancer, pembrolizumab for advanced vulvar cancer Mar 22, 2021
<ѻýҕl>Hormonal IUD Shows Promise in Early Endometrial Cancerѻýҕl> Regression seen in 82% of women with precancerous lesions Mar 21, 2021
<ѻýҕl>Practice-Changing Trial in Second-Line Endometrial Cancerѻýҕl> Pembrolizumab plus lenvatinib improved median OS by nearly 7 months versus chemotherapy Mar 19, 2021
<ѻýҕl>Class of Cancer Drug Linked to Aneurysms, Artery Dissectionsѻýҕl> Database analysis finds more reports than expected with antiangiogenic drugs Mar 18, 2021
<ѻýҕl>Acupuncture Tops Usual Care for Pain in Cancer Survivorsѻýҕl> Two types of acupuncture proved superior, with one better than the other Mar 18, 2021
<ѻýҕl>Whole-Genome Sequencing Makes a Case in Leukemia Studyѻýҕl> More actionable alterations detected in myeloid malignancies versus cytogenetics Mar 10, 2021
<ѻýҕl>New Targeted Therapies Show Promise in Cancerѻýҕl> Selected abstracts from the ESMO Targeted Anticancer Therapies virtual meeting Mar 03, 2021
<ѻýҕl>New Standard in High-Risk Muscle-Invasive Bladder Cancer?ѻýҕl> Adjuvant nivolumab improves DFS in all comers, PD-L1 population Feb 13, 2021
<ѻýҕl>Survival Boost in Bladder Cancer With Antibody-Drug Conjugateѻýҕl> Four-month absolute improvement with enfortumab vedotin in previously treated disease Feb 12, 2021
<ѻýҕl>AGA Updates Guidelines for Refractory H. Pyloriѻýҕl> New info stresses knowing patients' antibiotic exposure and doing drug susceptibility testing Feb 01, 2021
<ѻýҕl>First-Ever Survival Bump in Relapsed Mesotheliomaѻýҕl> OS, PFS improved with nivolumab, but questions remain about alternatives, biomarkers Jan 30, 2021
<ѻýҕl>JAK Inhibitor Misses Endpoint in Safety Study. Now What?ѻýҕl> Major blow to popular class of oral rheumatology drugs Jan 27, 2021
<ѻýҕl>Montana Oncologist Fired for Misdiagnosing, Overtreating Patientsѻýҕl> But some rally around him Jan 26, 2021
<ѻýҕl>Telehealth's Security Problem; Virtual Cancer Care; Post-Pandemic Teladocѻýҕl> Emerging trends in telemedicine and telehealth Jan 25, 2021
<ѻýҕl>Ozempic Seeking High Dose OK; Thyroid Cancer Overdiagnosed in Kids?ѻýҕl> News and commentary from the endocrinology world Jan 24, 2021
<ѻýҕl>Cancer and COVID; Booze and Cancer; 'Screech' Starts Chemoѻýҕl> News, features, and commentary about cancer-related issues Jan 21, 2021
<ѻýҕl>Preop RT Flunks Test in Borderline Pancreatic Cancerѻýҕl> Chemotherapy alone judged efficacious but not chemoradiation Jan 20, 2021
<ѻýҕl>Drug Hits Target in Advanced Biliary Cancerѻýҕl> Responses in up to a third of patients with FGFR inhibitor infigratinib Jan 19, 2021
<ѻýҕl>New Target to Attack in Stomach Cancerѻýҕl> PFS, OS improved with fibroblast growth factor receptor inhibitor in non-HER2 disease Jan 16, 2021
<ѻýҕl>Nuanced View of Oral Sex, HPV+ Oropharyngeal Cancerѻýҕl> Age at first oral sex, 'intensity,' number of partners all influence risk Jan 13, 2021
<ѻýҕl>Medicare's 'Most Favored Nation' Drug-Pricing Rule in Limboѻýҕl> Rule affecting Part B drugs was to take effect Jan. 1 but was stopped by federal court orders Jan 07, 2021
<ѻýҕl>Young-Onset Esophageal Cancer Rapidly Increasingѻýҕl> Physicians should be on the alert for younger patients with dysphagia, researchers urge Dec 16, 2020
<ѻýҕl>Study Reassures on MS Patients' Breast, Colorectal Cancer Riskѻýҕl> But higher incidence of other cancers in Canadian data Nov 25, 2020
<ѻýҕl>Potential New Option in Aggressive, Ultra Rare Sarcomaѻýҕl> Highly durable responses with nab-sirolimus in malignant PEComa Nov 21, 2020
<ѻýҕl>Cellular Therapies Promising in Advanced Synovial Sarcomaѻýҕl> Two different strategies yield impressive results in patients with recurrent or metastatic disease Nov 20, 2020
<ѻýҕl>Tiny Lung Micronodules in Bone Sarcoma Not Even a Tiny Problem?ѻýҕl> Five-year survival no worse in patients with micronodules under 5 mm Nov 20, 2020
<ѻýҕl>IL-8 Antibody Active in Tumors After PD-1/L1 Blockadeѻýҕl> Clinical benefit in more than a third of patients with anti-IL-8/nivolumab combo Nov 13, 2020
<ѻýҕl>IVF Babies With Birth Defects Also Show Increased Cancer Riskѻýҕl> Absolute risk is small, but findings should prompt further research Oct 29, 2020
<ѻýҕl>New-Onset Diabetes and Pancreas Cysts a Risky Mixѻýҕl> Study provides support for assessing diabetes markers in pancreatic cyst surveillance Oct 28, 2020
<ѻýҕl>High-Dose SBRT More Effective for Painful Spine Metastasesѻýҕl> Roughly one-third of patients had a complete pain response at 3 and 6 months Oct 26, 2020
<ѻýҕl>Anal Cancer on the Rise in U.S., Especially in Womenѻýҕl> Whites also had a higher risk than Blacks for HPV-linked disease Oct 26, 2020
<ѻýҕl>COVID-19 Plus Cancer Proves Deadlyѻýҕl> Over a third of cancer patients sent to the ICU died Oct 22, 2020
<ѻýҕl>Suze Orman's Schwannomaѻýҕl> Financial guru talks about her "most vital and stupid mistake" Oct 19, 2020
<ѻýҕl>Look for Bone Mets at Soft Tissue Sarcoma Diagnosisѻýҕl> Lung scan only would have missed 40% of all metastases, majority of bone disease, study finds Oct 12, 2020
<ѻýҕl>Eddie Van Halen's Head and Neck Cancerѻýҕl> A look at what caused the legendary guitarist's death Oct 12, 2020
<ѻýҕl>With H. Pylori, Higher-Dose PPIs May Promote Gastric Intestinal Metaplasiaѻýҕl> Retrospective Israeli study comes with many caveats, however Sep 24, 2020
<ѻýҕl>These Forbes 400 Billionaires Made Their Fortunes in Healthcareѻýҕl> 14 individuals, $66 billion in combined net worth Sep 24, 2020
<ѻýҕl>Positive Anti-PD-1 Data in Gastric, Esophageal Cancerѻýҕl> Better OS, PFS with nivolumab, pembrolizumab in advanced/metastatic disease Sep 23, 2020
<ѻýҕl>No Luck for Chemo-Free Tx in First-Line Bladder Cancerѻýҕl> Durvalumab alone or with tremelimumab no better than chemotherapy Sep 22, 2020